Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sun Pharma received US FDA acceptance of BLA for Tildrakizumab
Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis
Novartis India announces results for the quarter and year ended March 31, 2017
During FY 2016-2017 total income stood at ₹ 726.4 crore in comparison to ₹ 770.8 crore recorded in the previous corresponding…
GNH imports Olaratumab to India
It is a monoclonal antibody developed for the treatment of solid tumours soft tissue sarcomas
GNH India, pharmaceutical…
Ozone Ayurvedics launches herbal solution for dry eyes
Enriched with 11 organic herbal actives, ITIS Plus Care Eye Drops brings relief to tired and irritated eyes
DSP wins patent infringement case against Sinopharm
High Court of Delhi grants permanent injunction against the manufacture and sale of Sinopharm's amoxicillin active pharmaceutical…
DoP asks manufacturers to disseminate revised price information to retailers, distributors and…
Documentary evidence of communication may protect manufacturers from the claim of overcharging the medicine
Govt rolls out fruit-flavoured TB tablets for children
The initiative has been rolled out in five states and by next month, it will be introduced in 17 more states
Children suffering…
Pharma industry welcomes GST move, expects better rates
By Swati Rana-Mumbai
Further clarifications are needed before it comes into force
The much awaited Goods and Services Tax (GST)…
‘Our priority areas of growth and focus will be on human pharma and animal health’
Boehringer Ingelheim, a global pharma major, recently announced its plans to strategically realign its business focus areas.…
India to unveil new drug policy: Officials
According to GN Singh, Drug Controller General (India) a set of new procedures to facilitate clinical trials are expected to be…